Logo image of REAX

REAL BROKERAGE INC/THE (REAX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:REAX - CA75585H2063 - Common Stock

4.27 USD
+0.39 (+10.05%)
Last: 1/9/2026, 11:51:08 AM
Fundamental Rating

4

Overall REAX gets a fundamental rating of 4 out of 10. We evaluated REAX against 63 industry peers in the Real Estate Management & Development industry. The financial health of REAX is average, but there are quite some concerns on its profitability. REAX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

REAX had negative earnings in the past year.
REAX had a positive operating cash flow in the past year.
REAX had negative earnings in each of the past 5 years.
Of the past 5 years REAX 4 years had a positive operating cash flow.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

REAX has a worse Return On Assets (-7.28%) than 68.25% of its industry peers.
REAX has a Return On Equity of -19.54%. This is in the lower half of the industry: REAX underperforms 63.49% of its industry peers.
Industry RankSector Rank
ROA -7.28%
ROE -19.54%
ROIC N/A
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

REAX has a Gross Margin of 8.64%. This is in the lower half of the industry: REAX underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of REAX has declined.
REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

6

2. Health

2.1 Basic Checks

REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REAX has more shares outstanding
REAX has more shares outstanding than it did 5 years ago.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

REAX has an Altman-Z score of 16.85. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.85, REAX belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.85
ROIC/WACCN/A
WACC8.83%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.36 indicates that REAX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.36, REAX is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
REAX has a Quick Ratio of 1.36. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.36, REAX is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

REAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.
REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 65.60%.
The Revenue has been growing by 140.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%

3.2 Future

REAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.02% yearly.
The Revenue is expected to grow by 32.58% on average over the next years. This is a very strong growth
EPS Next Y67.21%
EPS Next 2Y38.82%
EPS Next 3Y35.02%
EPS Next 5YN/A
Revenue Next Year59.94%
Revenue Next 2Y39.55%
Revenue Next 3Y32.58%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

REAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year REAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of REAX indicates a rather cheap valuation: REAX is cheaper than 90.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.66
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

REAX's earnings are expected to grow with 35.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.82%
EPS Next 3Y35.02%

More info and screens

0

5. Dividend

5.1 Amount

REAX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

REAL BROKERAGE INC/THE

NASDAQ:REAX (1/9/2026, 11:51:08 AM)

4.27

+0.39 (+10.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)03-04 2026-03-04/bmo
Inst Owners43.9%
Inst Owner Change0%
Ins Owners11.42%
Ins Owner ChangeN/A
Market Cap904.39M
Revenue(TTM)1.81B
Net Income(TTM)-10.55M
Analysts86
Price Target6.46 (51.29%)
Short Float %2.06%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)196.08%
Min EPS beat(2)100%
Max EPS beat(2)292.16%
EPS beat(4)4
Avg EPS beat(4)120.81%
Min EPS beat(4)34.64%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)53.29%
EPS beat(12)8
Avg EPS beat(12)36.56%
EPS beat(16)11
Avg EPS beat(16)27.77%
Revenue beat(2)2
Avg Revenue beat(2)7.15%
Min Revenue beat(2)4.42%
Max Revenue beat(2)9.88%
Revenue beat(4)4
Avg Revenue beat(4)8.27%
Min Revenue beat(4)4.24%
Max Revenue beat(4)14.54%
Revenue beat(8)8
Avg Revenue beat(8)11.77%
Revenue beat(12)12
Avg Revenue beat(12)13.69%
Revenue beat(16)16
Avg Revenue beat(16)19.94%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-18.18%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.5
P/FCF 13.66
P/OCF 12.92
P/B 17.06
P/tB 22.9
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.31
FCFY7.32%
OCF(TTM)0.33
OCFY7.74%
SpS8.56
BVpS0.25
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.28%
ROE -19.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.64%
FCFM 3.65%
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover12.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 219.77%
Cap/Sales 0.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 16.85
F-Score7
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)186.01%
Cap/Depr(5y)132.24%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y67.21%
EPS Next 2Y38.82%
EPS Next 3Y35.02%
EPS Next 5YN/A
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%
Revenue Next Year59.94%
Revenue Next 2Y39.55%
Revenue Next 3Y32.58%
Revenue Next 5YN/A
EBIT growth 1Y65.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year321.46%
EBIT Next 3Y78.43%
EBIT Next 5YN/A
FCF growth 1Y212.51%
FCF growth 3Y133.43%
FCF growth 5YN/A
OCF growth 1Y216.48%
OCF growth 3Y131.69%
OCF growth 5YN/A

REAL BROKERAGE INC/THE / REAX FAQ

What is the fundamental rating for REAX stock?

ChartMill assigns a fundamental rating of 4 / 10 to REAX.


Can you provide the valuation status for REAL BROKERAGE INC/THE?

ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.


Can you provide the profitability details for REAL BROKERAGE INC/THE?

REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.


What is the financial health of REAL BROKERAGE INC/THE (REAX) stock?

The financial health rating of REAL BROKERAGE INC/THE (REAX) is 6 / 10.


What is the earnings growth outlook for REAL BROKERAGE INC/THE?

The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 67.21% in the next year.